Biochem/physiol Actions Selumetinib (ARRY-142886: AZD6244) is an orally active, potent and selective MEK1/2 inhibitor (MEK1 IC50 = 14 nM: <:20% inhibition of >:40 other kinases at 10 µ:M) that effectively downregulates cellular ERK1/2
Biochem/physiol Actions Selumetinib (ARRY-142886: AZD6244) is an orally active, potent and selective MEK1/2 inhibitor (MEK1 IC50 = 14 nM: <:20% inhibition of >:40 other kinases at 10 µ:M) that effectively downregulates cellular ERK1/2
Biochem/physiol Actions Selumetinib (ARRY-142886: AZD6244) is an orally active, potent and selective MEK1/2 inhibitor (MEK1 IC50 = 14 nM: <:20% inhibition of >:40 other kinases at 10 µ:M) that effectively downregulates cellular ERK1/2
Biochem/physiol Actions Selumetinib (ARRY-142886: AZD6244) is an orally active, potent and selective MEK1/2 inhibitor (MEK1 IC50 = 14 nM: <:20% inhibition of >:40 other kinases at 10 µ:M) that effectively downregulates cellular ERK1/2
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the